Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
57 studies found for:    formaldehyde
Show Display Options
Rank Status Study
1 Withdrawn Role of Indoor Pollutants on House Dust Mite Allergic Asthma
Conditions: Allergic Asthma;   Allergy to House Dust Mite
Interventions: Other: Formaldehyde and NO2 (Exposure to indoor pollutants);   Other: Placebo (Exposure to indoor pollutants)
2 Completed Studying Blood Toxicity in Workers Exposed to Formaldehyde
Conditions: Formaldehyde;   Hematotoxicity;   Leukemia
Intervention:
3 Completed Association of Formaldehyde Exposure to Myeloid Leukemia in Workers in Guangdong, China
Conditions: Epidemiology;   Industrial Hygiene;   Neoplasms
Intervention:
4 Completed Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine
Condition: Ross River Virus Disease (RRVD)
Intervention: Biological: Formalin-treated, UV-inactivated, whole-virion, Vero cell-derived, preservative free Ross River Virus (RRV) vaccine with or without an Al(OH)3 adjuvant
5 Completed Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
6 Completed Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
7 Completed Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
8 Unknown  Safety of Formalin-free Fixatives for In-Vivo Fixation of Skin Lesions.
Condition: Skin Abnormality
Intervention: Device: Formulations for in-vivo fixation
9 Completed Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology
Conditions: Basal Cell Carcinoma;   Squamous Cell Carcinoma
Intervention:
10 Recruiting Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
Conditions: Soil-transmitted Helminthiasis;   Schistosomiasis;   Strongyloidiasis;   Shigellosis;   Intestinal Salmonellosis;   Campylobacteriosis;   Aeromonas Spp. Infections;   Giardiasis;   Amoebiasis;   Dientamoebiasis;   Cryptosporidium Spp. Infections
Interventions: Procedure: Stool culturing for pathogenic bacteria;   Procedure: Kato-Katz technique;   Procedure: Baermann technique;   Device: Mini-FLOTAC;   Device: Crypto/Giardia Duo Strip;   Procedure: Formalin-ether concentration technique;   Device: CCA RDT;   Procedure: Koga agar plate culture;   Procedure: Kinyoun staining;   Device: Multiplex PCR;   Procedure: Metagenomics analysis
11 Completed Influence of Persistent CMV-infection on Immune Senescence
Condition: Immune Senescence
Intervention: Biological: Vaccination against TBEV (FSME Immun CC)
12 Terminated Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Tumor Sample;   Procedure: Serum Sample
13 Completed Chlorhexidine Mouthrinses and Plaque Control
Condition: Dental Plaque
Interventions: Drug: Synthodont;   Drug: Soludent
14 Recruiting Rates of Middle Meatal Synechia Formation Following Functional Endoscopic Sinus Surgery
Condition: Sinusitis.
Interventions: Device: Silastic Spacer;   Device: Merocel Spacer
15 Terminated Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis
Condition: Epistaxis
Interventions: Drug: Thrombin-JMI;   Drug: Merocel pack
16 Completed An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer
Condition: Breast Cancer
Intervention: Drug: celecoxib 400 mg BID
17 Unknown  Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial
Condition: Lymphoma
Interventions: Genetic: gene expression analysis;   Other: laboratory biomarker analysis
18 Completed An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg
Condition: Breast Cancer
Intervention: Drug: letrozole 2.5 mg
19 Completed
Has Results
A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)
Condition: Hepatitis A Virus Infection
Intervention: Biological: Hepatitis A Vaccine, Purified Inactivated (VAQTA™)
20 Completed Clinical Verification of Peptide Biomarkers for Human Aging
Condition: Aging
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years